|
Number
|
9
|
20
| |
|
Male preponderance, N (%)
|
6 (66.7)
|
12 (60)
|
0.7308
|
|
Age
|
74.2 ± 7.9
|
76.1 ± 6.4
|
0.6869
|
|
History
|
|
Hypertension
|
5
|
11
|
0.9778
|
|
Diabetes mellitus
|
0
|
2
|
0.2128
|
|
Hyperlipidemia
|
3
|
6
|
0.858
|
|
Anti-coagulant/platelet drugs
|
1
|
8
|
0.0988
|
|
Lacunar stroke
|
1
|
2
|
0.928
|
|
Alzheimer’s disease
|
0
|
3
|
0.1417
|
|
Chronic kidney disease
|
0
|
1
|
0.0713
|
|
Chronic obstructive pulmonary disease
|
0
|
1
|
0.0713
|
|
Activity of daily life
|
|
Modified Rankin scale (G2, 3, 4)/(G0–4) (%)
|
0
|
95
|
<0.0001*
|
|
Symptoms (iNPHGS)
|
|
Gait disturbance (G2–4)/(G0–4) (%)
|
0
|
85
|
<0.0001*
|
|
Cognition disturbance (G2–4)/(G0–4) (%)
|
0
|
85
|
<0.0001*
|
|
Urination disturbance (G2–4)/(G0–4) (%)
|
0
|
75
|
0.0009*
|
|
Tap test
|
|
TUG (baseline) (s)
|
NA
|
35.0 ± 47.7
| |
|
TUG (% change)
|
NA
|
25.6 ± 34.6
| |
|
MMSE (baseline score)
|
NA
|
21.4 ± 5.9
| |
|
MMSE (difference)
|
NA
|
3.1 ± 2.9
| |
|
Shunt surgery, N
|
0
|
12
| |
